Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04730609 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
A Phase 4 study of Shivering and Dose Finding Study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04730609 is a Phase 4 study of Shivering and Dose Finding Study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04730609, a Phase 4 study of Shivering and Dose Finding Study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04730609
The ClinicalTrials.gov registry entry for NCT04730609 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Shivering appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT04730609 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04730609 about?
NCT04730609 is a clinical study titled "Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery". The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
What is the current status of trial NCT04730609?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2021-09-21. Estimated completion is 2026-08.
What conditions does trial NCT04730609 study?
This clinical trial studies the following conditions: Shivering, Dose Finding Study.
What interventions are being tested in trial NCT04730609?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT04730609?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04730609 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.